Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan
Go back to Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 69.32 +0.65 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.67 | 52 Week High | $19.98 | |||
| Open | $69.85 | 52 Week Low | $10.52 | |||
| Day High | $70.99 | P/E | N/A | |||
| Day Low | $68.50 | EPS | $-1.45 | |||
| Volume | 508,631 | |||||
